Sastre-Garau X, Lacombe M L, Jouve M, Véron M, Magdelénat H
Section Médicale et Hospitalière, Institut Curie; Paris, France.
Int J Cancer. 1992 Feb 20;50(4):533-8. doi: 10.1002/ijc.2910500406.
The product of the nm23-H1 gene, reported to be a metastatic suppressor gene, was recently identified as the nucleoside diphosphate (NDP) kinase A, and was found to be overexpressed in several types of malignant tumors as compared with normal tissues. In order to determine whether NDP-kinase expression serves as a marker for metastatic potential and whether hyperproliferation of neoplastic cells would correlate with expression, we analyzed NDP-kinase levels and activity by immunohistochemical staining and by an enzymatic assay in 13 benign and 98 malignant breast-tissue specimens. Our results confirm that NDP-kinase expression increases in malignant cells of breast carcinomas, but cannot be considered as a biological marker of metastatic dissemination. No correlation was found between NDP-kinase activity and S phase, taken as an index of cell proliferation. Moreover, no correlation was observed between NDP-kinase activity and tumor size, histoprognostic index, estrogen receptors or progesterone receptors. The mechanism of over-expression of NDP in malignant cells and its role in tumor progression remain to be determined.
据报道,nm23-H1基因的产物是一种转移抑制基因,最近被鉴定为核苷二磷酸(NDP)激酶A,并且发现与正常组织相比,它在几种恶性肿瘤中过度表达。为了确定NDP激酶表达是否作为转移潜能的标志物,以及肿瘤细胞的过度增殖是否与表达相关,我们通过免疫组织化学染色和酶促测定法分析了13例良性和98例恶性乳腺组织标本中的NDP激酶水平和活性。我们的结果证实,乳腺癌恶性细胞中的NDP激酶表达增加,但不能被视为转移扩散的生物学标志物。未发现NDP激酶活性与作为细胞增殖指标的S期之间存在相关性。此外,未观察到NDP激酶活性与肿瘤大小、组织预后指数、雌激素受体或孕激素受体之间存在相关性。NDP在恶性细胞中过表达的机制及其在肿瘤进展中的作用仍有待确定。